|
1
|
Ghosh AC, Dohi T, Kang BH and Altieri DC:
Hsp60 regulation of tumor cell apoptosis. J Biol Chem.
283:5188–5194. 2008.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Huang YH and Yeh CT: Functional
compartmentalization of HSP60-survivin interaction between
mitochondria and cytosol in cancer Cells. Cells.
9(23)2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Li XS, Xu Q, Fu XY and Luo WS: Heat shock
protein 60 overexpression is associated with the progression and
prognosis in gastric cancer. PLoS One. 9(e107507)2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Desmetz C, Bibeau F, Boissière F, Bellet
V, Rouanet P, Maudelonde T, Mangé A and Solassol J:
Proteomics-based identification of HSP60 as a tumor-associated
antigen in early stage breast cancer and ductal carcinoma in situ.
J Proteome Res. 7:3830–3837. 2008.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Tsai YP, Yang MH, Huang CH, Chang SY, Chen
PM, Liu CJ, Teng SC and Wu KJ: Interaction between HSP60 and
beta-catenin promotes metastasis. Carcinogenesis. 30:1049–1057.
2009.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zhang R, Li YH, Hou XL, Miao ZH and Wang
Y: Neuroprotective effect of heat shock protein 60 on
matrine-suppressed microglial activation. Exp Ther Med.
14:1832–1836. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ding FJ, Li F, Li YH, Hou XL, Ma Y, Zhang
N, Ma J, Zhang R, Lang B, Wang HY and Wang Y: HSP60 involved in
neuroprotective effects of curcumin by suppressing microglia
activation. Exp Ther Med. 12:823–828. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Cheng WJ, Li YH, Qi Q, Wang L, Ding FJ, Li
F, Miao ZH, Yang SQ, Li GH, Wang J, et al: HSP60 is involved in the
neuroprotective effects of Naloxone. Mol Med Rep. 10:2172–2176.
2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Wang Y, Chen L, Hagiwara N and Knowlton
AA: Regulation of heat shock protein 60 and 72 expression in the
failing heart. J Mol Cell Cardiol. 48:360–366. 2010.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lin L, Kim SC, Wang Y, Gupta S, Davis B,
Simon SI, Torre-Amione G and Knowlton AA: HSP60 in heart failure:
Abnormal distribution and localization to lipid rafts. Am J Physiol
Heart Circ Physiol. 293:H2238–H2247. 2007.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Vocka M, Langer D, Fryba V, Petrtyl J,
Hanus T, Kalousova M, Zima T and Petruzelka L: Novel serum markers
HSP60, CHI3L1, and IGFBP-2 in metastatic colorectal cancer. Oncol
Lett. 18:6284–6292. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ding F, Li Y, Hou X, Zhang R, Hu S and
Wang Y: Oxymatrine inhibits microglia activation via HSP60-TLR4
signaling. Biomed Rep. 5:623–628. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Korniluk A, Koper O, Kemona H and
Dymicka-Piekarska V: From inflammation to cancer. Ir J Med Sci.
186:57–62. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kocaadam B and Şanlier N: Curcumin, an
active component of turmeric (Curcuma longa), and its effects on
health. Crit Rev Food Sci Nutr. 57:2889–2895. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Pluta R, Ułamek-Kozioł M and Czuczwar SJ:
Neuroprotective and neurological/cognitive enhancement effects of
curcumin after brain ischemia injury with Alzheimer's disease
phenotype. Int J Mol Sci. 19(4002)2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Rashid K, Chowdhury S, Ghosh S and Sil PC:
Curcumin attenuates oxidative stress induced NFκB mediated
inflammation and endoplasmic reticulum dependent apoptosis of
splenocytes in diabetes. Biochem Pharmacol. 143:140–155.
2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Patel SS, Acharya A, Ray RS, Agrawal R,
Raghuwanshi R and Jain P: Cellular and molecular mechanisms of
curcumin in prevention and treatment of disease. Crit Rev Food Sci
Nutr. 60:887–939. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Devassy JG, Nwachukwu ID and Jones PJ:
Curcumin and cancer: Barriers to obtaining a health claim. Nutr
Rev. 73:155–165. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Panchal HD, Vranizan K, Lee CY, Ho J, Ngai
J and Timiras PS: Early anti-oxidative and anti-proliferative
curcumin effects on neuroglioma cells suggest therapeutic targets.
Neurochem Res. 33:1701–1710. 2008.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zhang Y, Tu L, Zhou X and Li B:
Curcumin-mediated induction of apoptosis in human glioma CHME
cells. Med Sci Monit Basic Res. 24:216–224. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Seyithanoğlu MH, Abdallah A, Kitiş S,
Güler EM, Koçyiğit A, Dündar TT and Gündağ Papaker M: Investigation
of cytotoxic, genotoxic, and apoptotic effects of curcumin on
glioma cells. Cell Mol Biol (Noisy-le-grand). 65:101–108.
2019.PubMed/NCBI
|
|
22
|
Cheng C, Jiao JT, Qian Y, Guo XY, Huang J,
Dai MC, Zhang L, Ding XP, Zong D and Shao JF: Curcumin induces G2/M
arrest and triggers apoptosis via FoxO1 signaling in U87 human
glioma cells. Mol Med Rep. 13:3763–3770. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhang Z, Li C, Tan Q, Xie CJ, Yang YY,
Zhan WG, Han F, Sharma SH and Sharma A: Curcumin suppresses tumor
growth and angiogenesis in human glioma cells through modulation of
vascular endothelial growth factor/angiopoietin-2/thrombospondin-1
signaling. CNS Neurol Disord Drug Targets. 16:346–350.
2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Perry MC, Demeule M, Régina A, Moumdjian R
and Béliveau R: Curcumin inhibits tumor growth and angiogenesis in
glioblastoma xenografts. Mol Nutr Food Res. 54:1192–1201.
2010.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Cui G, Yuan A, Sun Z, Zheng W and Pang Z:
IL-1β/IL-6 network in the tumor microenvironment of human
colorectal cancer. Pathol Res Pract. 214:986–992. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
van Horssen R, Ten Hagen TL and Eggermont
AM: TNF-alpha in cancer treatment: Molecular insights, antitumor
effects, and clinical utility. Oncologist. 11:397–408.
2006.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Deguchi A: Curcumin targets in
inflammation and cancer. Endocr Metab Immune Disord Drug Targets.
15:88–96. 2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wang XP, Wang QX, Lin HP and Chang N:
Anti-tumor bioactivities of curcumin on mice loaded with gastric
carcinoma. Food Funct. 8:3319–3326. 2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Liao F, Liu L, Luo E and Hu J: Curcumin
enhances anti-tumor immune response in tongue squamous cell
carcinoma. Arch Oral Biol. 92:32–37. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kunnumakkara AB, Bordoloi D, Harsha C,
Banik K, Gupta SC and Aggarwal BB: Curcumin mediates anticancer
effects by modulating multiple cell signaling pathways. Clin Sci
(Lond). 131:1781–1799. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Sun Y, Zheng J, Xu Y and Zhang X:
Paraquat-induced inflammatory response of microglia through
HSP60/TLR4 signaling. Hum Exp Toxicol. 37:1161–1168.
2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Jakic B, Buszko M, Cappellano G and Wick
G: . Elevated sodium leads to the increased expression of HSP60 and
induces apoptosis in HUVECs. PLoS One. 12(e0179383)2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Juwono J and Martinus RD: Does Hsp60
provide a link between mitochondrial stress and inflammation in
diabetes mellitus? J Diabetes Res. 2016(8017571)2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Caruso Bavisotto C, Cappello F, Macario
AJL, Macario de EC, Logozzi M, Fais S and Campanella C: Exosomal
HSP60: A potentially useful biomarker for diagnosis, assessing
prognosis, and monitoring response to treatment. Expert Rev Mol
Diagn. 17:815–822. 2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Shetab Boushehri MA and Lamprecht A:
TLR4-based immunotherapeutics in cancer: A review of the
achievements and shortcomings. Mol Pharm. 15:4777–4800.
2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Chen X, Zhao F, Zhang H, Zhu Y, Wu K and
Tan G: Significance of TLR4/MYD88 expression in breast cancer. Int
J Clin Exp Pathol. 8:7034–7039. 2015.PubMed/NCBI
|
|
37
|
Jing X, Tian Z, Gao P, Xiao H, Qi X, Yu Y,
Ding X, Yang L and Zong L: HBsAg/β2GPI activates the NF-κB pathway
via the TLR4/MyD88/IκBα axis in hepatocellular carcinoma. Oncol
Rep. 40:1035–1045. 2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Sokolova O and Naumann M: NF-κB signaling
in gastric cancer. Toxins (Basel). 9(119)2017.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Liu B, Sun L, Liu Q, Gong C, Yao YD, Lv
XB, Lin L, Yao HR, Su FX, Li DS, et al: A cytoplasmic NF-κB
interacting long noncoding RNA blocks IκB phosphorylation and
suppresses breast cancer metastasis. Cancer Cell. 27:370–381.
2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Friedmann-Morvinski D, Narasimamurthy R,
Xia Y, Myskiw C, Soda Y and Verma IM: Targeting NF-κB in
glioblastoma: A therapeutic approach. Sci Adv.
2(e1501292)2016.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Martins GR, Gelaleti GB, Moschetta MG,
Maschio-Signorini LB and Zuccari DA: Proinflammatory and
anti-inflammatory cytokines mediated by NF-κB factor as prognostic
markers in mammary tumors. Mediators Inflamm.
2016(9512743)2016.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Das S, Shapiro B, Vucic EA, Vogt S and
Bar-Sagi D: Tumor cell-derived il1β promotes desmoplasia and immune
suppression in pancreatic cancer. Cancer Res. 80:1088–1101.
2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Hehlgans T and Männel DN: The TNF-TNF
receptor system. Biol Chem. 383:1581–1585. 2002.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Roos WP, Thomas AD and Kaina B: DNA damage
and the balance between survival and death in cancer biology. Nat
Rev Cancer. 16:20–33. 2016.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Chen J: The cell-cycle arrest and
apoptotic functions of p53 in tumor initiation and progression.
Cold Spring Harb Perspect Med. 6(a026104)2016.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Galluzzi L, Kepp O and Kroemer G:
Caspase-3 and prostaglandins signal for tumor regrowth in cancer
therapy. Oncogene. 31:2805–2808. 2012.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Sam MR and Pourpak RS: Regulation of p53
and survivin by prodigiosin compound derived from Serratia
marcescens contribute to caspase-3-dependent apoptosis in acute
lymphoblastic leukemia cells. Hum Exp Toxicol. 37:608–617.
2018.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Oblak A and Jerala R: Toll-like receptor 4
activation in cancer progression and therapy. Clin Dev Immunol.
2011(609579)2011.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Sawa-Wejksza K and Kandefer-Szerszeń M:
Tumor-associated macrophages as target for antitumor therapy. Arch
Immunol Ther Exp (Warsz). 66:97–111. 2018.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Lai WY, Wang JW, Huang BT, Lin EP and Yang
PC: A novel TNF-α-targeting aptamer for TNF-α-mediated acute lung
injury and acute liver failure. Theranostics. 9:1741–1751.
2019.PubMed/NCBI View Article : Google Scholar
|
